Risk of having BRCA1 mutation in high‐risk women with triple‐negative breast cancer: a meta‐analysis

Testing for BRCA1 mutation has important clinical implications such as identifying risk of second primary cancers and risk of cancer in the family. This study seeks to quantify the risk of having BRCA1 mutation in female breast cancer patients with triple-negative phenotype compared with those with ... View More